Karel Fol serves on the Business Advisory Board of Epihunter, a health technology company dedicated to enhancing the lives of individuals with neurological conditions, particularly epilepsy.

In this role, Karel contributes his extensive experience in the (Bio)Pharma and Medical Devices sectors to guide Epihunter’s strategic direction, business development, and market expansion efforts. His insights are instrumental in helping the company navigate the complexities of the healthcare industry and in bringing innovative solutions to those affected by neurological disorders.